TY - JOUR T1 - Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US JO - Cost Effectiveness and Resource Allocation PY - 2020/10/06 AU - Thokala P AU - Stevenson M AU - Kumar VM AU - Ren S AU - Ellis AG AU - Chapman RH ED - DO - DOI: 10.1186/s12962-020-00234-8 PB - Springer Science and Business Media LLC VL - 18 Y2 - 2025/04/15 ER -